Central nervous system agents for ischemic stroke: neuroprotection mechanisms
about
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategiesTargeting brain microvascular endothelial cells: a therapeutic approach to neuroprotection against strokeMelatonin and Ischemic Stroke: Mechanistic Roles and ActionClass I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion injury.Hemin offers neuroprotection through inducing exogenous neuroglobin in focal cerebral hypoxic-ischemia in rats.Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.Hyperglycemia as a Risk Factor of Ischemic StrokeNeuroprotective effects of Buyang Huanwu decoction on cerebral ischemia-induced neuronal damage.L-serine treatment may improve neurorestoration of rats after permanent focal cerebral ischemia potentially through improvement of neurorepairDiscovery of 3-n-butyl-2,3-dihydro-1H-isoindol-1-one as a potential anti-ischemic stroke agentBone marrow derived mesenchymal stem cells alleviated brain injury via down-regulation of interleukin-1β in focal cerebral ischemic ratsEffects of Xiaoshuan enteric-coated capsule on neurovascular functions assessed by quantitative multiparametric MRI in a rat model of permanent cerebral ischemiaNeuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic ratsLuoyutong Treatment Promotes Functional Recovery and Neuronal Plasticity after Cerebral Ischemia-Reperfusion Injury in RatsAdministration of mesenchymal stem cells and ziprasidone enhanced amelioration of ischemic brain damage in rats.N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury.Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia-reperfusion injury in rats by targeting multiple cellular processesDietary and circulating lycopene and stroke risk: a meta-analysis of prospective studiesNitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reactionElectrical stimulation of cerebellar fastigial nucleus: mechanism of neuroprotection and prospects for clinical application against cerebral ischemia.Chemical modification of the multitarget neuroprotective compound fisetin.NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives.Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.Potential Therapeutic Mechanisms and Tracking of Transplanted Stem Cells: Implications for Stroke Treatment.Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats.Combination effect of memantine and mesenchymal stem cells on the recovery of brain damage in a rat model of brain ischemia
P2860
Q26740083-9A8AD6F5-07A1-42E5-90B0-8C9903311E18Q26775047-CCEE2095-E5FB-4B42-B4A3-6470526FBABDQ26782228-B8680AB3-083F-4248-B0D9-A5432C395908Q27303057-F40FE1B1-FC4A-4FF1-A5EB-741752F6C487Q33802941-C151DA01-C767-446D-B671-30021B137735Q34222849-7F5D0032-0B70-46D3-8D55-81776A778D48Q34342764-C5C7E967-A6B4-4625-9143-2213D480FF79Q34412794-3B772CD6-7FF4-4C2A-A3C0-C7E548BDE5CFQ35132210-64A67F06-EE29-4A86-8CF2-9FB48687629DQ35822017-43BF3B1A-0AAB-4A07-AA97-BA3ADBE0F432Q36019568-5D1631B3-7BAF-42D9-B66A-CD50183184D3Q36071562-B6C0C2EB-59DA-47EF-990F-A2E7F4F3FFF8Q36183200-0F3E0CA6-7BCE-412D-8518-9F8087A076B5Q36369456-BAEBE581-303C-4157-84A3-04CEF5D0F1CAQ37462629-4D4CD600-175A-44EA-8BEF-FF4C88F65623Q37594138-C8B24219-1D39-43E1-8D43-6409869968F3Q37733195-F5DB52F7-9612-4564-A3B2-4F64EBB95FD0Q37738379-C8D10642-77FB-4B8F-8CBD-E655EEE06ECCQ38108307-2DB0229C-7961-4692-9AE7-7C2209CED664Q38220376-F6EDB94F-44E1-4484-AD4B-7D6D2F076B82Q39423915-9428574C-5BC1-4436-9ECE-0B63224A1E2AQ39496194-808B6BCD-536A-488A-850F-1E445FE500AFQ41239829-5C691C8F-0884-4618-901C-FB3CF68901A9Q41623285-766E840F-9950-4AB6-AE22-E1237461E467Q41912784-1AEF8326-5E31-4E3B-B9CB-464E6021BFF9Q52098933-77890444-AA5D-4D36-8A36-37D45A6089E9Q58295800-8D931A60-C3E6-4C6E-A1B0-FEFF5B59FC21
P2860
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
@ast
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
@en
type
label
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
@ast
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
@en
prefLabel
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
@ast
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
@en
P2093
P2860
P1476
Central nervous system agents for ischemic stroke: neuroprotection mechanisms
@en
P2093
A John Popp
Jiang Zeng
Lijuan Mao
Rachna S Pandya
Shuanhu Zhou
P2860
P356
10.2174/187152411796011321
P577
2011-06-01T00:00:00Z